In a letter addressed to House Speaker Nancy Pelosi (D-CA) and House Republican Leader Kevin McCarthy (R-CA), 138 emerging biotech leaders warn that H.R. 3, the Lower Drug Cost Now Act, will “shatter the dreams” of patients and families who stand to benefit from the extraordinary science happening…
In comments to the Securities and Exchange Commission (SEC), BIO applauds the SEC for taking a proactive approach in amending the exemptions from the proxy rules for proxy voting. If adopted, the proposal will significantly improve proxy firm transparency without sacrificing investor protection…
Letters, Testimony & Comments | February 4, 2020 | BIO Announcements
The undersigned national agricultural organizations wish to extend our support for the nomination of Michael Regan to serve as Administrator of the Environmental Protection Agency.
Read the letter below:
Letters, Testimony & Comments | March 26, 2021 | Bio Economy
The Biotechnology Innovation Organization is delighted to support the Inventor Diversity for Economic Advancement Act of 2021 and urge swift enactment of this important measure.
Dr. Michelle McMurry-Heath, along with a group of business and policy leaders, sends an open letter to President Biden urging him "to demonstrate decisive U.S. leadership" to combat COVID-19 in Latin America, Europe, Asia, and Africa.
Letters, Testimony & Comments | May 28, 2021 | Biotechnology Innovation Organization (BIO), BIO Announcements
BIO applauds your leadership in the development and introduction of the Sustainable Skies Act, a blender’s tax credit (BTC) to incentivize the production and use of sustainable aviation fuel (SAF).
To meet the challenge of climate change, it is crucial to lead with science and U.S. innovation…
The partnership between the biopharmaceutical industry and the U.S. Government is largely responsible for where we are with the COVID-19 pandemic today. In just 16 months from the declaration of the pandemic, cases have dramatically dropped as more than 50% of U.S. adults have gotten vaccinated,…
The undersigned CEOs of global biotechnology companies and associations have a social responsibility to work with other stakeholders – healthcare providers, governments, multilateral organizations, and non-governmental donor organizations – to ensure that COVID vaccines and treatments get to the…